Mesothelioma shows promising response to existing immunotherapy drug – Medical News Today
Medical News Today |
Mesothelioma shows promising response to existing immunotherapy drug
Medical News Today An existing immunotherapy drug called pembrolizumab appears to be effective in the treatment of malignant pleural mesothelioma, a rare and aggressive lung cancer that is primarily caused by exposure to asbestos. Writing in The Lancet Oncology, … |
